Hocking, Samantha http://orcid.org/0000-0002-2514-9392
Sumithran, Priya http://orcid.org/0000-0002-9576-1050
Funding for this research was provided by:
National Health and Medical Research Council (1178482)
University of Melbourne
Article History
Accepted: 24 April 2023
First Online: 18 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: SH: Fees for serving on advisory boards for Novo Nordisk, Inova and Eli Lilly, honoraria for presentations from Novo Nordisk, iNova, Eli Lilly, Astra Zeneca, Servier, Sanofi Aventis and Pfizer, co-author of manuscripts with medical writing assistance provided by Novo Nordisk and Eli Lilly. Unpaid positions at National Association of Clinical Obesity Services (President) and The Obesity Collective (leadership group). Research grants paid to the Institution from National Health and Medical Research Council, Diabetes Australia and Novo Nordisk. PS: Research grants paid to the Institution from National Health and Medical Research Council, co-author of manuscripts with medical writing assistance provided by Novo Nordisk. Unpaid position at The Obesity Collective (leadership group).